Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Walking away from heart failure blues: study tests 12-Week home program

NCT ID NCT06791967

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 12-week home-based walking program could help heart failure patients with depression, frailty, and quality of life. 68 patients were split into two groups: one got standard health education, the other added a walking routine of 3,000 extra steps per session, five times a week. Researchers measured changes in mood, frailty, and daily well-being over three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
home-based walking exercise program
What this could lead to
If successful, this walking program could offer a simple, low-cost way to improve mood, reduce frailty, and enhance quality of life for people with heart failure.
What could go wrong
This is a small, single-center study with only 68 participants. Results may not apply to all heart failure patients, and the program requires motivation to stick with it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

68 people

The number who actually took part.

Started

Mar 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with heart failure classified as New York Heart Association (NYHA) Functional Class II-III by a physician. * Approval from the attending physician to participate in the home-based walking program after discharge. * Aged between 18 and 80 years. * Patients unable to attend outpatient cardiac rehabilitation. * No regular exercise habits, such as performing less than 30 minutes of aerobic exercise per week. * Able to walk independently without the aid of assistive devices. * Patients with clear consciousness, no cognitive impairment, and no history of mental illness. * Able to communicate in Mandarin or Taiwanese dialect. * Willing to participate in the study, sign the informed consent form, and comply with the home-based walking program. Exclusion Criteria: * Patients diagnosed with heart failure classified as New York Heart Association (NYHA) functional class IV by a physician. * Patients diagnosed with depression by a psychiatrist. * Patients with cognitive impairment or language communication disorders. * Patients who are bedridden for an extended period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Taiwan University Hospital

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.